Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
report tags : Biotech-beach save search
Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
NBIX | News 4 | $138.97 -0.8% -0.85% 930K
|
Health Technology
|
| O: 5.49%
H: 2.84%
C: -0.65%
nbi-1065 positive for
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results
Published: 2024-03-21 (Crawled : 22:00) - biospace.com/
DRMA | $0.3568 5.03% -2.75% 19K
|
|
| O: 2.5%
H: 7.95%
C: -2.44%
year update therapeutics financial results
Ensysce Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-15 (Crawled : 13:00) - biospace.com/
ENSC | $0.5586 0.05% 1.58% 43K
|
Health Technology
|
| O: 0.0%
H: 8.0%
C: 5.81%
year financial results
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-07 (Crawled : 23:00) - biospace.com/
ERNA | $1.74 -11.22% -8.89% 13K
|
Information
|
| O: 3.16%
H: 0.0%
C: -0.5%
LCTX | $1.1 -3.51% 0.0% 750K
|
Health Technology
|
| O: 1.77%
H: 0.0%
C: -1.74%
business year update cell therapeutics financial results
Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
Published: 2024-03-06 (Crawled : 17:00) - biospace.com/
AADI | $1.78 -3.26% -2.79% 110K
|
Manufacturing
|
| O: 0.47%
H: 4.72%
C: 2.83%
report bioscience update results
Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-29 (Crawled : 23:00) - biospace.com/
PBYI | $4.83 -5.85% -5.99% 370K
|
Health Technology
|
| O: 4.09%
H: 4.08%
C: -9.46%
year financial results
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
LCTX | $1.1 -3.51% 0.0% 750K
|
Health Technology
|
| O: 1.92%
H: 1.89%
C: -1.89%
report business year update cell therapeutics financial results
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 19:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
INBX | $34.38 0.73% 0.74% 220K
|
Health Technology
|
| O: -0.86%
H: 0.13%
C: -5.66%
year financial results
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview
Published: 2024-02-27 (Crawled : 23:00) - biospace.com/
ACAD | News | $16.59 -0.9% -1.03% 1.3M
|
Health Technology
|
| O: 0.54%
H: 2.0%
C: 1.23%
year pharmaceuticals financial results
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 13:00) - biospace.com/
TVTX | $5.45 -5.05% -5.13% 940K
|
Health Technology
|
| O: 2.37%
H: 1.46%
C: 1.22%
MRK | $127.0 0.1% 0.63% 5.7M
|
Health Technology
|
| O: -0.45%
H: 0.7%
C: 0.6%
HTGC 4 | $18.96 0.58% 0.0% 570K
|
Finance
|
| O: -2.77%
H: 0.47%
C: -0.27%
VKTX | $65.07 0.22% 0.15% 2.4M
|
Health Technology
|
| O: 81.31%
H: 29.0%
C: 21.9%
VRNA | $15.24 -2.25% -2.5% 320K
|
Health Technology
|
| O: 2.1%
H: 2.83%
C: -0.5%
LGND | $71.0 1.59% 1.38% 110K
|
Health Technology
|
| O: 14.46%
H: 11.02%
C: 4.72%
ALDX | $3.94 0.77% 0.51% 530K
|
Health Technology
|
| O: 1.91%
H: 2.68%
C: 1.07%
year financial results
Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
Published: 2024-02-13 (Crawled : 00:00) - biospace.com/
LGND | $71.0 1.59% 1.38% 110K
|
Health Technology
|
| O: -3.04%
H: 1.92%
C: -3.19%
report year financial results
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-02-13 (Crawled : 00:00) - biospace.com/
QDEL | News 4 | $40.82 1.04% 1.0% 950K
|
Health Technology
|
| O: -3.51%
H: 2.61%
C: -0.49%
financial results
Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Published: 2024-02-07 (Crawled : 23:00) - biospace.com/
VKTX | $65.07 0.22% 0.15% 2.4M
|
Health Technology
|
| O: 0.85%
H: 0.36%
C: -1.37%
LGND | $71.0 1.59% 1.38% 110K
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: -0.8%
update therapeutics financial results
Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - February 1, 2024
Published: 2024-02-01 (Crawled : 22:00) - biospace.com/
ONCT | $8.545 -2.51% -0.11% 1.6K
|
Health Technology
|
| O: -2.66%
H: 6.01%
C: -0.53%
award nasdaq therapeutics
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
Published: 2023-11-09 (Crawled : 00:00) - biospace.com/
MEIP | $3.26 -2.17% -2.22% 7.4K
|
Health Technology
|
| O: 0.42%
H: 2.21%
C: -2.62%
pharma year results
Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-09 (Crawled : 00:00) - biospace.com/
LCTX | $1.1 -3.51% 0.0% 750K
|
Health Technology
|
| O: 0.91%
H: 2.69%
C: -3.6%
business update cell therapeutics financial results
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023
Published: 2023-11-09 (Crawled : 00:00) - biospace.com/
HCA 4 | $319.02 -0.13% 0.0% 840K
|
Health Services
|
| O: 1.06%
H: 0.85%
C: -2.75%
ILMN | $122.87 -1.28% -1.4% 720K
|
Health Technology
|
| O: 0.68%
H: 0.15%
C: -4.01%
year financial results
Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®
Published: 2023-11-07 (Crawled : 00:00) - biospace.com/
EOLS | $11.5 -1.71% -1.92% 260K
|
Health Technology
|
| O: 0.38%
H: 2.5%
C: 1.0%
jeuveau financial results
Janux Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
Published: 2023-11-07 (Crawled : 00:00) - biospace.com/
JANX | $48.21 -3.15% -3.41% 580K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 8.96%
C: 4.96%
business therapeutics financial results
Xencor Reports Third Quarter 2023 Financial Results
Published: 2023-11-07 (Crawled : 00:00) - biospace.com/
XNCR | $19.02 3.54% 3.57% 760K
|
Health Technology
|
| O: -0.05%
H: 1.41%
C: 0.82%
OMER | $3.04 -1.62% -1.64% 250K
|
Health Technology
|
| O: -1.47%
H: 11.57%
C: 5.97%
MOR | News | $18.05 0.06% 0.17% 130K
|
Health Technology
|
| O: 0.36%
H: 0.48%
C: -1.09%
GILD | $67.08 0.08% 0.06% 6.2M
|
Health Technology
|
| O: -0.09%
H: 0.35%
C: -0.57%
AMGN | News | $273.01 -0.19% -0.17% 1.5M
|
Health Technology
|
| O: 0.05%
H: 0.38%
C: -0.68%
financial results
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.